至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Production of Human Papillomavirus Type-16 L1 VLP in Pichia pastoris

Applied Biochemistry and Microbiology. 2020; 
A. Sanchoolia, b, Kh. Aghayipourb, Sh. Karimi Naghlanib, Z. Samieeb, B. Abedi Kiasarib, and M. Makvandi a
Products/Services Used Details Operation
Molecular Biology Tools Codon adaptation index (CAI) was analyzed using online genscript software (www.genscript.com) before and after the optimization. Get A Quote

摘要

Human papillomavirus-16 (HPV-16) is primary etiological agent of invasive cervical cancer development in the world population. There is no treatment for HPV infection. As a possible tool for prophylactic vaccination, the development of virus-like particles (VLPs) comprising the HPV-16 L1 capsid protein is highly preferred. The expression of HPV-16 L1 gene was carried out in Pichia pastoris. It was done as a promising vaccine candidate against HVP-16 infection for developing countries. The codon optimization for HPV-16 L1 gene was done and synthesized in pPICZA plasmid. The expression of HPV-16 L1 was evaluated in P. pastoris after induction with methanol. The purification of HPV-16 VLPs was accomplished by the ... More

关键词

HPV-16 L1 protein, human papillomavirus (HPV), Pichia pastoris, virus-like particle (VLP)